Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: A pilot clinical study

Journal of Hepatology

Volumn 49, Issue 2, 2008, Pages 217-222

  Lencioni, Riccardo ^a   Crocetti, Laura ^a   Petruzzi, Pasquale ^a   Vignali, Claudio ^a   Bozzi, Elena ^a   Della Pina, Clotilde ^a   Bargellini, Irene ^a   Cioni, Dania ^a   Oliveri, Filippo ^b   De Simone, Paolo ^b   Bartolozzi, Carlo ^a   Brunetto, Maurizia ^b   Filipponi, Franco ^b  

^a Division of Diagnostic and Interventional Radiology   (Italy)

^b Cisanello University Hospital   (Italy)

Author keywords

Doxorubicin; Hepatocellular carcinoma; Radiofrequency ablation

Indexed keywords

DOXORUBICIN;

ADULT; AGED; ALOPECIA; ARTICLE; BONE MARROW TOXICITY; CANCER GROWTH; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG ELUTING STENT; DRUG SAFETY; DYSPNEA; EMBOLISM; FEMALE; FOLLOW UP; HUMAN; LIVER ABSCESS; LIVER CELL CARCINOMA; LIVER FUNCTION; LUNG EMBOLISM; MALE; NECROSIS; POSTEMBOLIZATION SYNDROME; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; TREATMENT RESPONSE; TUMOR VOLUME; VOMITING;

AGED; AGED, 80 AND OVER; ANGIOGRAPHY; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CATHETER ABLATION; COMBINED MODALITY THERAPY; DOXORUBICIN; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MICROSPHERES; MIDDLE AGED; PILOT PROJECTS; TREATMENT OUTCOME;

EID: 46249116195     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2008.03.021     Document Type: Article

References (27)

1. Parkin D.M., Bray F., Ferlay J., and Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 55 (2005) 74-108
2. Bruix J., Sherman M., Llovet J.M., Beaugrand M., Lencioni R., Burroughs A.K., et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35 (2001) 421-430
3. Bruix J., and Sherman M. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208-1236
4. Llovet J.M., Schwartz M., and Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 25 (2005) 181-200
5. Llovet J.M., Fuster J., and Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology 30 (1999) 1434-1440
6. Lencioni R., Allgaier H.P., Cioni D., Olschewski M., Deibert P., Crocetti L., et al. Small hepatocellular carcinoma in cirrhosis: randomized comparison of radiofrequency thermal ablation versus percutaneous ethanol injection. Radiology 228 (2003) 235-240
7. Lin S.M., Lin C.J., Lin C.C., Hsu C.W., and Chen Y.C. Radiofrequency ablation improves prognosis compared with ethanol injection for hepatocellular carcinoma < or =4 cm. Gastroenterology 127 (2004) 1714-1723
8. Shiina S., Teratani T., Obi S., Sato S., Tateishi R., Fujishima T., et al. A randomized controlled trial of radiofrequency ablation versus ethanol injection for small hepatocellular carcinoma. Gastroenterology 129 (2005) 122-130
9. Lu D.S., Yu N.C., Raman S.S., Limanond P., Lassman C., Murray K., et al. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology 234 (2005) 954-960
10. Goldberg S.N., Girnan G.D., Lukyanov A.N., Ahmed M., Monsky W.L., Gazelle G.S., et al. Percutaneous tumor ablation: increased necrosis with combined radio-frequency ablation and intravenous liposomal doxorubicin in a rat breast tumor model. Radiology 222 (2002) 797-804
11. Ahmed M., Liu Z., Lukyanov A.N., Signoretti S., Horkan C., Monsky W.L., et al. Combination radiofrequency ablation with intratumoral liposomal doxorubicin: effect on drug accumulation and coagulation in multiple tissues and tumor types in animals. Radiology 235 (2005) 469-477
12. Varela M., Real M.I., Burrel M., Forner A., Sala M., Brunet M., et al. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics. J Hepatol 46 (2007) 474-481
13. Poon R.T., Tso W.K., Pang R.W., Ng K.K., Woo R., Tai K.S., et al. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. Clin Gastroenterol Hepatol 5 (2007) 1100-1108
14. Goldberg S.N., Charboneau J.W., Dodd GD I.I.I., Dupuy D.E., Gervais D.A., Gillams A.R., et al. Image-guided tumor ablation: proposal for standardization of terms and reporting criteria. Radiology 228 (2003) 335-345
15. Lencioni R., Cioni D., Crocetti L., Franchini C., Pina C.D., Lera J., et al. Early-stage hepatocellular carcinoma in cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation. Radiology 234 (2005) 961-967
16. Tateishi R., Shiina S., Teratani T., Obi S., Sato S., Koike Y., et al. Percutaneous radiofrequency ablation for hepatocellular carcinoma. Cancer 103 (2005) 1201-1209
17. Cabassa P., Donato F., Simeone F., Grazioli L., and Romanini L. Radiofrequency ablation of hepatocellular carcinoma: long-term experience with expandable needle electrodes. AJR Am J Roentgenol 185 (2006) S316-S321
18. Choi D., Lim H.K., Rhim H., Kim Y.S., Lee W.J., Paik S.W., et al. Percutaneous radiofrequency ablation for early-stage hepatocellular carcinoma as a first-line treatment: long-term results and prognostic factors in a large single-institution series. Eur Radiol 17 (2007) 684-692
19. Chen M.S., Li J.Q., Zheng Y., Guo R.P., Liang H.H., Zhang Y.Q., et al. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243 (2006) 321-328
20. Goldberg S.N., Gazelle G.S., and Mueller P.R. Thermal ablation therapy for focal malignancies: a unified approach to underlying principles, techniques, and diagnostic imaging guidance. AJR Am J Roentgenol 174 (2000) 323-331
21. Goldberg S.N., Hahn P.F., Tanabe K.K., Mueller P.R., Schima W., Athanasoulis C.A., et al. Percutaneous radiofrequency tissue ablation: does perfusion-mediated tissue cooling limit coagulation necrosis?. J Vasc Interv Radiol 9 (1998) 101-111
22. Rossi S., Garbagnati F., Lencioni R., Allgaier H.P., Marchianò A., Fornari F., et al. Percutaneous radio-frequency thermal ablation of nonresectable hepatocellular carcinoma after occlusion of tumor blood supply. Radiology 217 (2000) 119-126
23. Veltri A., Moretto P., Doriguzzi A., Pagano E., Carrara G., Gandini G., et al. Radiofrequency thermal ablation (RFA) after transarterial chemoembolization (TACE) as a combined therapy for unresectable non-early hepatocellular carcinoma (HCC). Eur Radiol 16 (2006) 661-669
24. Helmberger T., Dogan S., Straub G., Schrader A., Jüngst C., Reiser M., et al. Liver resection or combined chemoembolization and radiofrequency ablation improve survival in patients with hepatocellular carcinoma. Digestion 75 (2007) 104-112
25. Yamasaki T., Kurokawa F., Shirahashi H., Kusano N., Hironaka K., and Okita K. Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow. Comparison with standard percutaneous radiofrequency ablation therapy. Cancer 95 (2002) 2353-2360
26. Lewis A.L., Gonzales M.V., Lloyd A.W., Hall B., Tang Y., Willis S.L., et al. DC bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J Vasc Interv Radiol 17 (2006) 335-342
27. Sala M., Llovet J.M., Vilana R., Bianchi L., Solé M., Ayuso C., et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology 40 (2004) 1352-1360